Fluid-fluid levels in transcalvarial Langerhans’ cell histiocytosis
✍ Scribed by Ajay Taranath; Ella Onikul
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 152 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0301-0449
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Guided by a long-term retrospective observa-bone lesions (n ϭ 27), which remained asymption, the clinical course and treatment of Langer-tomatic or showed a remission to treatment, hans'-cell histiocytosis (LCH) in adult patients multifocal LCH had a more aggressive course. are represented. The seri
A study of 47 well-documented patients with Langerhans cell histiocytosis (LCH) showed a slight female preponderance, with onset as late as the ninth decade. The skin was the commonest site of presentation, but pulmonary and bone involvement was frequent. Patients with single-site disease did best.
Background. Because prostaglandin (PG) E2 has been identified in the bone lesions of Langerhans cell histiocytosis (LCH), we speculated that indomethacin, a potent PG inhibitor, may be useful in patients with symptomatic LCH involving the bony skeleton. Procedure. We used indomethacin to treat patie